Source-grounded facts extracted from Vivos Therapeutics, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Dr. G. Dave Singh was terminated as Chief Medical Officer at Vivos Therapeutics, Inc..
“provided Dr. G. Dave Singh, the Company’s Chief Medical Officer (“Dr. Singh”), with notice of termination of his employment with the Company “for cause” pursuant to the terms Dr. Singh’s employment agreement with the Company, dated October 9, 2020.”
Dr. G. Dave Singh resigned as director at Vivos Therapeutics, Inc..
“he has resigned as a member of the Company’s board of directors (the “Board”), effective September 22, 2021.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.